Differences in Imaging Characteristics of HPV-Positive and HPV-Negative Oropharyngeal Cancers: A Blinded Matched-Pair Analysis

BACKGROUND AND PURPOSE: Human papillomavirus–positive oropharyngeal cancers typically have younger age of onset, limited tobacco exposure, and more favorable prognosis than HPV-negative oropharyngeal cancers. We assessed whether HPV-positive and HPV-negative oropharyngeal cancers have consistent differences in pretreatment imaging characteristics. MATERIALS AND METHODS: A retrospective review of 136 pretreatment CT examinations of paired HPV-positive and HPV-negative oropharyngeal cancers matched for T stage, tumor subsite, and smoking status was performed with the reviewing radiologist blinded to HPV status and clinical stage. Demographic/clinical characteristics and imaging characteristics of primary lesions and metastatic nodal disease were compared by use of Fisher exact testing. The McNemar χ2 test was used for the matched-pair analysis. RESULTS: By imaging, HPV-negative tumors were more likely to demonstrate invasion of adjacent muscle (26% versus 6%, P = .013). HPV-positive primary tumors were more likely to be enhancing and exophytic with well-defined borders, whereas HPV-negative primary tumors were more likely to be isoattenuated and demonstrate ill-defined borders, though these results were not statistically significant. HPV-positive tumors were more likely to demonstrate cystic nodal metastases than HPV-negative tumors (36% versus 9%, P = .002). CONCLUSIONS: In this matched and blinded analysis of the imaging differences between HPV-positive and HPV-negative oropharyngeal cancers, HPV-positive carcinomas often had primary lesions with well-defined borders and cystic nodal metastases, whereas HPV-negative primaries more often had poorly defined borders and invasion of adjacent muscle.

[1]  J. Shah,et al.  Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation , 2013, Head & neck.

[2]  K. Ang,et al.  The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Q. Wei,et al.  Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites , 2011, Head & neck.

[4]  Gypsyamber D'Souza,et al.  HPV-associated head and neck cancer: a virus-related cancer epidemic. , 2010, The Lancet. Oncology.

[5]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[6]  P. Hudgins,et al.  Second Branchial Cleft Cyst: NOT!! , 2009, American Journal of Neuroradiology.

[7]  E. Speel,et al.  Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications , 2009, Clinical Cancer Research.

[8]  C. Tsien,et al.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Califano,et al.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenon , 2008, Head & neck.

[10]  Q. Wei,et al.  p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. , 2008, Carcinogenesis.

[11]  W. Westra,et al.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.

[12]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  E. Sturgis,et al.  Trends in head and neck cancer incidence in relation to smoking prevalence , 2007, Cancer.

[14]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[15]  D. Rimm,et al.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  A. Carvalho,et al.  Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database , 2005, International journal of cancer.

[17]  B. Schmidt,et al.  Tongue and tonsil carcinoma , 2005, Cancer.

[18]  F. Metternich,et al.  The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[19]  C. Gourin,et al.  Incidence of Unsuspected Metastases in Lateral Cervical Cysts , 2000, The Laryngoscope.

[20]  A. Berghold,et al.  Cystic lymph node metastases of squamous cell carcinoma of Waldeyer's ring origin , 1999, British Journal of Cancer.

[21]  K. Olsen,et al.  Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. , 1994, Archives of otolaryngology--head & neck surgery.

[22]  N. Roland,et al.  Cervical node metastases presenting with features of branchial cysts , 1994, The Journal of Laryngology & Otology.

[23]  B. Miles,et al.  Laryngeal Squamous Cell Carcinoma , 2014 .

[24]  R. Ferris,et al.  Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. , 2007, European journal of cancer.

[25]  L. Thompson,et al.  The clinical importance of cystic squamous cell carcinomas in the neck: a study of 136 cases. , 1998, Cancer.